ConductScience.org, home

Paper39508604

Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.

Xiong Y and 10 others. J Virol, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein. Papers, record 39508604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39508604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.
PubMed
Journal
J Virol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.69, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xiong YYingcaihttps://orcid.org/0009-0002-2417-6847
2Tao KKeyu
3Li TTao
4Zhou YYinghui
5Zhang ZZhaowei
6Ou WWeiying
7Wang ZZhao
8Wang SShouchuan
9Hou YYayi
10Cao PPenghttps://orcid.org/0000-0002-2044-3074
11Ji JJianjianhttps://orcid.org/0000-0002-4336-0589

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydrolyzable TanninsMajor topic
Virus InternalizationMajor topic
Antiviral AgentsMajor topic
Viral Fusion ProteinsMajor topic
Respiratory Syncytial Virus InfectionsMajor topic
Virus ReplicationMajor topic
Humans
Animals
Mice
Glycoproteins
Respiratory Syncytial Virus, Human
Cell Line
Heparan Sulfate Proteoglycans
Benzopyrans
Glucosides

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2023YFC2308200MOST | National Key Research and Development Program of China (NKPs)PubMed
82374524MOST | National Natural Science Foundation of China (NSFC)PubMed
2021-QNRC2-B14Young Elite scientists sponsorship Program by CACMPubMed
021093002906| Natural Science Research of Jiangsu Higher Education Institutions of China (Natural Science Foundation of Colleges and Universities in Jiangsu Province)PubMed

Source PubMed

Download CSV of grants

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129464672Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants.Pharmacoecon Open2018https://conductscience.org/library/papers/29464672PubMed
234125371Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-κB signaling pathway.Sci China Life Sci2022https://conductscience.org/library/papers/34125371PubMed
338160942Current state and challenges in respiratory syncytial virus drug discovery and development.Antiviral Res2024https://conductscience.org/library/papers/38160942PubMed
430254193Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding.Emerg Microbes Infect2018https://conductscience.org/library/papers/30254193PubMed
538270052Resveratrol inhibits respiratory syncytial virus replication by targeting heparan sulfate proteoglycans.Food Funct2024https://conductscience.org/library/papers/38270052PubMed
626719246Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System.J Virol2015https://conductscience.org/library/papers/26719246PubMed
736280532Development of mRNA vaccines against respiratory syncytial virus (RSV).Cytokine Growth Factor Rev2022https://conductscience.org/library/papers/36280532PubMed
81698933Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells.J Nat Prod1990https://conductscience.org/library/papers/1698933PubMed
919723363The lack of protective immunity against RSV in the elderly.Epidemiol Infect2009https://conductscience.org/library/papers/19723363PubMed
1037098418Edible alginate-based films with anti-SARS-CoV-2 activity.Food Microbiol2023https://conductscience.org/library/papers/37098418PubMed
1122194690The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components.PLoS Pathog2011https://conductscience.org/library/papers/22194690PubMed
1234296672Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter?Euro Surveill2021https://conductscience.org/library/papers/34296672PubMed
1325558771Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis.Crit Rev Anal Chem2015https://conductscience.org/library/papers/25558771PubMed
1426658574Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.PLoS Pathog2015https://conductscience.org/library/papers/26658574PubMed
1528469033A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants.Sci Transl Med2017https://conductscience.org/library/papers/28469033PubMed
1624812523Respiratory syncytial virus: current and emerging treatment options.Clinicoecon Outcomes Res2014https://conductscience.org/library/papers/24812523PubMed
1729510663Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study.BMC Infect Dis2018https://conductscience.org/library/papers/29510663PubMed
1828761099Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.Nat Commun2017https://conductscience.org/library/papers/28761099PubMed
1936463892Decline of RSV-specific antibodies during the COVID-19 pandemic.Lancet Infect Dis2023https://conductscience.org/library/papers/36463892PubMed
2021208913Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab.J Infect Dis2011https://conductscience.org/library/papers/21208913PubMed

See all 66 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42790425Punicalin targets RSV glycoprotein and fusion protein at non-overlapping sites to prevent viral escape.Cell Rep Med2026https://conductscience.org/library/papers/42790425PubMed
41459485Multimodal cell death drives the immunopathogenesis of RSV infection.Front Immunol2025https://conductscience.org/library/papers/41459485PubMed
41236925Protoporphyrin IX targets viral spike glycoproteins to inactivate Akabane virus.Virulence2025https://conductscience.org/library/papers/41236925PubMed
41230964
New insight into the epidemiological trends of respiratory syncytial virus infection and the underlying anti-respiratory syncytial virus mechanisms of andrographolide: integrating Global Burden of Disease database, network pharmacological analysis, and in vitro experiments.
Microbiol Spectr2026https://conductscience.org/library/papers/41230964PubMed
41142773Virus infection and vesicle trafficking.Front Immunol2025https://conductscience.org/library/papers/41142773PubMed
40569507Potential use of plant secondary metabolites in the treatment of allergic respiratory diseases (ARDs).Mol Biol Rep2025https://conductscience.org/library/papers/40569507PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SDC26383PubTator's text mininghttps://conductscience.org/library/genes/6383

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39508604

GET https://conductscience.org/api/papers/v1/39508604/references?page=2